Controversy Over the Surrogacy of Proteinuria or Albuminuria for Cardiovascular Outcomes

医学 蛋白尿 蛋白尿 微量白蛋白尿 内科学 肾功能 糖尿病肾病 泌尿科 肾脏疾病 肌酐 血压 糖尿病
作者
Mohammad Hossein Panahi,Razieh Bidhendi Yarandi
出处
期刊:Canadian Journal of Cardiology [Elsevier BV]
卷期号:35 (9): 1256.e5-1256.e6 被引量:1
标识
DOI:10.1016/j.cjca.2019.04.024
摘要

We were pleased to read the excellent review by Harrison et al.,1Harrison T.G. Tam-Tham H. Hemmelgarn B.R. et al.Change in proteinuria or albuminuria as a surrogate for cardiovascular and other major clinical outcomes: a systematic review and meta-analysis.Can J Cardiol. 2019; 35: 77-91Abstract Full Text Full Text PDF PubMed Scopus (11) Google Scholar recently published in the Canadian Journal of Cardiology, entitled “Change in Proteinuria or Albuminuria as a Surrogate for Cardiovascular and Other Major Clinical Outcomes: A Systematic Review and Meta-analysis”. The authors declared that “There is ongoing controversy around the surrogacy of proteinuria or albuminuria, particularly for cardiovascular (CV) outcomes”; therefore, the aim of their review article was to assess the surrogacy of changing proteinuria or albuminuria for CV events, end-stage renal disease (ESRD), and all-cause mortality. Results of the study showed inconsistent treatment effects for proteinuria and CV events (20 trials; TER 1.11 [95% confidence interval (CI), 1.01-1.22]). Treatment effects on proteinuria or albuminuria were also inconsistent with the effects on all-cause mortality (21 trials; TER 1.17 [95% CI, 1.07-1.28]), and they concluded that “Change in proteinuria or albuminuria might be a suitable surrogate outcome for ESRD. However, overall treatment effects on these potential surrogates are inconsistent and overestimate the treatment effects on CV events and all-cause mortality.” Although the results were interesting, the obtained statistically significant level would be a matter of controversy. Borderline lower limits of 95% CIs made their significance level doubtable, whereas the 95% prediction interval (PI) suggested that the intervention effect could be null or even be in the opposite direction,2IntHout J. Ioannidis J.P.A. Rovers M.M. Goeman J.J. Plea for routinely presenting prediction intervals in meta-analysis.BMJ Open. 2016; 6: e010247Crossref PubMed Scopus (591) Google Scholar as PI presents a wider range of interval than CI. Therefore, to evaluate clinical significance, PI was proposed in contrast to statistical significance. To explain further, CI quantifies the accuracy of the mean, whereas PI addresses the actual dispersion of effect sizes, and the 2 measures are not interchangeable. We suggest that the authors calculate the prediction interval for evaluating clinical significances to reach more reliable results.3Borenstein M. Hedges L.V. Higgins J.P. Rothstein H.R. Introduction to Meta-Analysis. John Wiley & Sons, Hoboken, NJ2011Google Scholar We would like to mention another statistical issue as well. Meta-analysis uses normal distribution to estimate pooled CI (z-value), whereas relative risk (RR) follows a skewed distribution, which affects the results significantly. To tackle this issue, it would better to log-transform RR and pooled them and then inverse log by an exponential function and report RR instead of log-RR. The review authors did not mention, in the statistical part in the case, whether the process of analysis followed this point. We also assessed the methodological quality of this review using the 16-item A Measurement Tool to Assess Systematic Reviews (AMSTAR) 2 appraisal tool.4Shea B.J. Reeves B.C. Wells G. et al.AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.BMJ. 2017; 358: j4008Crossref PubMed Scopus (3100) Google Scholar According to AMSTAR 2, this study scored 16 items out of 16 (Table 1), so this systematic review provided an accurate and comprehensive summary of the results of the available studies that address the question of interest and is classified as high-quality, although the surrogacy of proteinuria or albuminuria for CV outcomes is still a matter of controversy.Table 1Methodological quality of the included meta-analyses and systematic reviews through AMSTAR 2ItemsN (%)1Did the research questions and inclusion criteria for the review include the components of PICO (population, intervention, control group, and outcome)?Yes2Did the report of the review contain an explicit statement that the review methods were established prior to conduct of the review, and did the report justify any significant deviations from the protocol?Yes3Did the review authors explain their selection of the study designs for inclusion in the review?Yes4Did the review authors use a comprehensive literature search strategy?Yes5Did the review authors perform study selection in duplicate?Yes6Did the review authors perform data extraction in duplicate?Yes7Did the review authors provide a list of excluded studies and justify the exclusions?Yes8Did the review authors describe the included studies in adequate detail?Yes9Did the review authors use a satisfactory technique for assessing the risk of bias (RoB) in individual studies that were included in the review?Yes10Did the review authors report on the sources of funding for the studies included in the review?Yes11If meta-analysis was justified, did the review authors use appropriate methods for statistical combination of results?Yes12If meta-analysis was performed, did the review authors assess the potential impact of RoB in individual studies on the results of the meta-analysis or other evidence synthesis?Yes13Did the review authors account for RoB in individual studies when interpreting/discussing the results of the review?Yes14Did the review authors provide a satisfactory explanation for—and discussion of—any heterogeneity observed in the results of the review?Yes15If they performed quantitative synthesis, did the review authors carry out an adequate investigation of publication bias (small study bias) and discuss its likely impact on the results of the review?Yes16Did the review authors report any potential sources of conflict of interest, including any funding they received for conducting the review?YesAMSTAR 2 ClassificationHighAMSTAR, A Measurement Tool to Assess Systematic Reviews. Open table in a new tab AMSTAR, A Measurement Tool to Assess Systematic Reviews. The authors have no conflicts of interest to disclose. Change in Proteinuria or Albuminuria as a Surrogate for Cardiovascular and Other Major Clinical Outcomes: A Systematic Review and Meta-analysisCanadian Journal of CardiologyVol. 35Issue 1PreviewThere is ongoing controversy around the surrogacy of proteinuria or albuminuria, particularly for cardiovascular (CV) outcomes, which remain the leading cause of morbidity and mortality among patients with chronic kidney disease. We performed a systematic review and meta-analysis of the literature to assess the surrogacy of changing proteinuria or albuminuria for CV events, end-stage renal disease (ESRD), and all-cause mortality. Full-Text PDF

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
RR完成签到,获得积分10
刚刚
小爱完成签到,获得积分10
刚刚
刚刚
chenkai发布了新的文献求助10
刚刚
缥缈的飞机完成签到,获得积分10
1秒前
shilly发布了新的文献求助30
1秒前
1秒前
2秒前
酷波er的应助被荷荷采纳,获得10
2秒前
2秒前
2秒前
1947188918完成签到,获得积分10
2秒前
2秒前
zxs666完成签到,获得积分10
3秒前
Winnie发布了新的文献求助10
3秒前
吴慧琼发布了新的文献求助10
3秒前
何佳发布了新的文献求助20
3秒前
随风逐梦完成签到,获得积分10
3秒前
3秒前
liwen发布了新的文献求助10
3秒前
空心白菜圆圆完成签到 ,获得积分10
3秒前
深情安青的应助被傑丨楽采纳,获得10
4秒前
15656869999发布了新的文献求助10
4秒前
MR_芝欧完成签到,获得积分10
4秒前
123123完成签到 ,获得积分20
4秒前
猫小乐C发布了新的文献求助10
4秒前
dfi完成签到,获得积分10
4秒前
jack完成签到,获得积分10
5秒前
跳动的蓝精灵完成签到,获得积分10
5秒前
执着的觅露完成签到,获得积分10
5秒前
yu完成签到,获得积分10
6秒前
Hibiscus95完成签到,获得积分10
6秒前
seiunsky完成签到,获得积分10
6秒前
6秒前
gxiaxia完成签到,获得积分20
6秒前
7秒前
zmm完成签到 ,获得积分10
7秒前
陈小安完成签到,获得积分10
7秒前
秀丽天川发布了新的文献求助10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology)求助 1000
Encyclopedia of Modern Artificial Intelligence 1000
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8152503
求助须知:如何正确求助?哪些是违规求助? 9549164
关于积分的说明 21691337
捐赠科研通 7740687
什么是DOI,文献DOI怎么找? 3425238
关于科研通互助平台的介绍 2550393
邀请新用户注册赠送积分活动 2468790